FDA NDC Directory · JSON-LD · Markdown

Abecma

NDC 59572-515 · CELLULAR THERAPY · SUSPENSION

Generic nameidecabtagene vicleucel
Labeler / ManufacturerCelgene Corporation
Marketing categoryBiologic License Application · App BLA125736
Dosage form / routeSUSPENSION · INTRAVENOUS
Active ingredientsIDECABTAGENE VICLEUCEL (300000000 1/1)
Marketing started20210326
Package count3

External sources

Source: openFDA. Public-domain (CC0).